US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 38.665
  • +0.485+1.27%
Trading Aug 29 14:16 ET
4.71BMarket Cap-14215P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
SYFOVRE154.62M77.43%
EMPAVELI24.51M12.28%
Licensing and other revenue20.55M10.29%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States396.59M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday+1.14%